Literature DB >> 3691477

Truncation does not abrogate transcriptional downregulation of the c-myc gene by sodium butyrate in Burkitt's lymphoma cells.

A Polack1, D Eick, E Koch, G W Bornkamm.   

Abstract

We have examined the effect of sodium butyrate, a potent inducer of differentiation in various cell systems, on the steady state RNA level and transcriptional activity of the c-myc gene in Burkitt's lymphoma cells. Following sodium butyrate treatment a rapid decrease of c-myc RNA was observed in all Burkitt's lymphoma cell lines studied, irrespective of the type of translocation, the location of the breakpoint relative to c-myc or of the association with EBV. Since cellular genes induced by interferon are suspected to play a role in c-myc regulation we have studied transcription of the 2-5A synthetase gene in sodium butyrate-treated Burkitt's lymphoma cells. Transcriptional activity and steady state mRNA levels of the 2-5A synthetase gene were induced by sodium butyrate. The time course of induction excluded, however, that the decrease of c-myc RNA is caused by induction of the 2-5A synthetase/RNase L endonuclease system. The reduction of c-myc RNA is caused, at least in part, by a reduced transcription rate, as shown by nuclear run-on analysis. The fact that sodium butyrate is capable of downregulating a truncated c-myc gene indicates that an important target site of transcriptional regulation is located outside the region encompassing the upstream regulatory sequences, the dual promoters and the leader region.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3691477      PMCID: PMC553732          DOI: 10.1002/j.1460-2075.1987.tb02601.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  55 in total

1.  Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate.

Authors:  J Luka; B Kallin; G Klein
Journal:  Virology       Date:  1979-04-15       Impact factor: 3.616

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Induction of erythroid differentiation in the human leukaemia cell line K562.

Authors:  L C Andersson; M Jokinen; C G Gahmberg
Journal:  Nature       Date:  1979-03-22       Impact factor: 49.962

4.  Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis.

Authors:  W S Hayward; B G Neel; S M Astrin
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

5.  Cytogenetic studies on African Burkitt's lymphoma cell lines: t(8;14), t(2;8) and t(8;22) translocations.

Authors:  A Bernheim; R Berger; G Lenoir
Journal:  Cancer Genet Cytogenet       Date:  1981-06

6.  Expression of cellular homologues of retroviral onc genes in human hematopoietic cells.

Authors:  E H Westin; F Wong-Staal; E P Gelmann; R Dalla-Favera; T S Papas; J A Lautenberger; A Eva; E P Reddy; S R Tronick; S A Aaronson; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

7.  Human immunoglobulin heavy chain genes: evolutionary comparisons of C mu, C delta and C gamma genes and associated switch sequences.

Authors:  T H Rabbitts; A Forster; C P Milstein
Journal:  Nucleic Acids Res       Date:  1981-09-25       Impact factor: 16.971

8.  Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.

Authors:  S J Collins; F W Ruscetti; R E Gallagher; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

9.  Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells.

Authors:  A Leder; P Leder
Journal:  Cell       Date:  1975-07       Impact factor: 41.582

10.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

Authors:  C Auffray; F Rougeon
Journal:  Eur J Biochem       Date:  1980-06
View more
  13 in total

1.  Sensitivity of an epstein-barr virus-positive tumor line, Daudi, to alpha interferon correlates with expression of a GC-rich viral transcript.

Authors:  Y Gao; S a Xue; B E Griffin
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  High rotational mobility of DNA in animal cells and its modulation by histone acetylation.

Authors:  W A Krajewski; A N Luchnik
Journal:  Mol Gen Genet       Date:  1991-12

3.  Relationship of histone acetylation to DNA topology and transcription.

Authors:  W A Krajewski; A N Luchnik
Journal:  Mol Gen Genet       Date:  1991-12

4.  Nucleosomal structures of c-myc promoters with transcriptionally engaged RNA polymerase II.

Authors:  T Albert; J Mautner; J O Funk; K Hörtnagel; A Pullner; D Eick
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

5.  The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation.

Authors:  C Van Lint; S Emiliani; E Verdin
Journal:  Gene Expr       Date:  1996

6.  Transcriptional consequences of topoisomerase inhibition.

Authors:  I Collins; A Weber; D Levens
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

Review 7.  Minireview: The versatile roles of lysine deacetylases in steroid receptor signaling.

Authors:  Vineela Kadiyala; Catharine L Smith
Journal:  Mol Endocrinol       Date:  2014-03-19

8.  Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription.

Authors:  F Rösl; B C Das; M Lengert; K Geletneky; H zur Hausen
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

9.  c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.

Authors:  A Polack; K Hörtnagel; A Pajic; B Christoph; B Baier; M Falk; J Mautner; C Geltinger; G W Bornkamm; B Kempkes
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

10.  Post-transcriptional mechanisms of deregulation of MYC following conversion of a human B cell line by Epstein-Barr virus.

Authors:  J Lacy; W P Summers; W C Summers
Journal:  EMBO J       Date:  1989-07       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.